{"id":"W3030083314","doi":"10.1200/jco.2020.38.15_suppl.102","title":"Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Fludarabine; Neutropenia; Leukopenia; Cyclophosphamide; Internal medicine; Febrile neutropenia; Regimen; Gastroenterology; Chemotherapy; Oncology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00139791,0.001226723,0.0009915554,0.0003505819,0.0003175542,0.0006503301,0.000737345,0.0009914119,0.004738867],"category_scores_gemma":[0.0006785202,0.0003818958,0.0005880379,0.0002912101,0.0005990866,0.0006500314,0.0003617663,0.00325459,0.0008602045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008059722,"about_ca_system_score_gemma":0.0008632175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004439267,"about_ca_topic_score_gemma":0.0008373201,"domain_scores_codex":[0.9996542,0.0001647327,0.00001565533,0.00004679122,0.00004031186,0.00007839709],"domain_scores_gemma":[0.9994481,0.00009797729,0.0001296394,0.00004820315,0.00003095817,0.000245106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5743747,0.1450182,0.01157419,0.0006641409,0.0008611872,0.0007779544,0.0005546566,0.006386844,0.1015447,0.000887815,0.01109889,0.1462568],"study_design_scores_gemma":[0.4520829,0.5221417,0.009851132,0.00003074387,0.0001878528,0.0006517502,0.00005326746,0.002587497,0.008419239,0.0004372197,0.003534676,0.00002218403],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942742,0.0006289578,0.0004188851,0.0003466776,0.00007012156,0.001954695,0.0005754411,0.00007004937,0.001660928],"genre_scores_gemma":[0.9908264,0.0004267465,0.001493526,0.0006066444,0.00008859815,0.002411093,0.001597078,0.00001850776,0.002531323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004738867,"threshold_uncertainty_score":0.01585311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2037260286482502,"score_gpt":0.5361714243604768,"score_spread":0.3324453957122266,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}